Skip to content

EFFECTS OF TELEPHARMACY IN ISCHEMIC STROKE PATIENTS

EFFECTS OF TELEPHARMACY IN ISCHEMIC STROKE PATIENTS

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250401004
Enrollment
130
Registered
2025-04-01
Start date
2024-02-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke Ischemic stroke Telepharmacy Medication adherence Medication-related problems

Interventions

Pharmaceutical care was provided once during hospitalization, followed by telepharmacy services via Telehealth Thailand and Line Official at 1 week, 1 month, and 2 months post-discharge. Follow-up wa
Experimental Other,No Intervention Other
Telepharmacy ,usual care

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years or older who have been diagnosed with, or have a documented history of, ischemic stroke (ICD-10: I63) and were admitted to the inpatient ward at Sam Chuk Hospital. 2. A score of 12 or higher on the Modified Barthel Index for Activities of Daily Living (ADL), indicating at least moderate functional independence. 3. A score of greater than 23 on the Thai Mental State Examination (TMSE), reflecting normal cognitive functioning. 4.Ability to read, speak, write, and communicate effectively in the Thai language. 5.Access to a communication device compatible with video conferencing platforms and a stable internet connection. 6.Willingness to participate in the study and provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1.Diagnosed with cognitive, perceptual, or memory-related disorders, such as Alzheimer disease or psychiatric conditions. 2.Demonstrating clinical deterioration to the extent that they are no longer able to perform basic self-care activities.

Design outcomes

Primary

MeasureTime frame
disease and medication knowledge, medication adherence, clinical outcomes (BP, LDL and HbA1c) and medication-related problems (MRPs) 3 month Disease and medication knowledge score (structured questionnaire),Medication Adherence Scale for Thais (MAST), BP LDL and HbA1c measured from standard hospital protocol, PCNE version 9.1

Countries

Thailand

Contacts

Public ContactARWORN CHAEMKIRI

Samchuk hospital

noiirx1234@gmail.com0618246280

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026